EVAX Evaxion Biotech: Multiplikator forward rega marang pendapatan
Risks for Evaxion Biotech A/S (EVAX) are linked to R&D expenditures and potential failures in clinical trials. However, the PIONEER and EDIVAX platforms accelerate vaccine development, providing a pricing power advantage. The expected P/S valuation demonstrates price action where the value has stabilized at 3.10. This confirms the brand authority of a company creating precise AI models for immunotherapy.
Rincian metrik komprehensif lan analitis Evaxion Biotech AS (EVAX)
- rega pasar lan target rega analis:
- data kapitalisasi saham perusahaan:
- rincian valuasi buku bisnis:
- statistik kawajiban utang lan likuiditas:
Total Utang marang Modal Evaxion Biotech A/S|EVAX - Koefisien utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Evaxion Biotech A/S|EVAX - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Evaxion Biotech AS|EVAX - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Evaxion|Rasio cepet evaxion-biotech.com
- rincian asil keuangan lan kelipatan valuasi:
EVAX - Penghasilan resik perusahaan|Bathi mangsa ngarep Evaxion Biotech A/S|EVAX - Rasio rega marang bathi|Pangali Forward P/E Evaxion Biotech Corp|EVAX - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Evaxion Biotech AS|EVAX - Bathi operasional sadurunge amortisasi|Bathi resik saben saham (EPS TTM) Evaxion|EVAX - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan evaxion-biotech.com|EVAX - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Evaxion Biotech A/S
- rincian pendapatan lan dodolan:
Ringkesan analisis perusahaan:Evaxion EVAX
The uniqueness of the Barriers AI platform and the patent protection of genomic data at Evaxion Biotech (EVAX) allow the market to price in a high premium to the company's projected P/S ratio. This indicator compares current market capitalization with expected revenue, neutralizing the lag of quarterly reports and enabling investors to promptly identify business overvaluation or an entry point when future cash flows are undervalued.
Pesaing Evaxion Biotech A/S
Rasio rega marang prakiraan pendapatan NVIDIA NVDA|CoreWeave, Inc. (CRWV) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|NBIS: Multiplikator forward rega marang pendapatan|SoundHound Corp - Rasio rega marang pendapatan sing dikarepake|ZETA: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep pagaya.com (PGY)|AI (C3 AI) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Recursion Pharmaceuticals Inc (RXRX)|Multiplikator Forward P/S RZLV|SUPX (Super X) - Rega forward marang dodolan|Ginkgo Bioworks Holdings - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan CRNC|Palladyne AI - Multiplikator Forward P/S|VERI - Multiplikator Forward P/S|mimintinc.com (MIMI) - Rasio rega marang prakiraan pendapatan|MLGO - Rasio kapitalisasi marang dodolan sing dikarepake|HPAI (Helport AI Ltd.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep liveperson.com LPSN|Multiplikator forward rega marang pendapatan QUIK (QuickLogic Corporation)|Rasio rega marang prakiraan pendapatan SST (system1.com)|Multiplikator Forward P/S DVLT (WiSA Technologies)|Multiplikator Forward P/S Ruanyun Technology RYET|WETO: Multiplikator forward rega marang pendapatan|MCRP (micropolis.ai) - Kapitalisasi marang prakiraan pendapatan|CYN: Multiplikator Forward P/S|Connexa Sports Technologies Inc. (YYAI) - Multiplikator Forward P/S|HOLO (MicroCloud Hologram, Inc.) - Multiplikator Forward P/S|Infrared Cameras Inc. (MSAI) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S AIXI|CXAI - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Brand Engagement Network Inc. - Multiplikator forward rega marang pendapatan|Gaxos.ai Inc - Rasio rega marang prakiraan pendapatan|Evogene, Ltd. - Multiplikator Forward P/S|IFBD - Multiplikator Forward P/S|TAOP (Taoping Inc.) - Multiplikator forward rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan VSAI|EXAI (Exscientia PLC) - Multiplikator Forward P/S|foxotechnologies.com (FOXO) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Vocodia Holdings Corp. (VHAI)|ZPTA - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep
